Atlas Trials

Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial

Clinical trial NCT02632864 · UNKNOWN

Trial details

NCT number
NCT02632864
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Liver NeoplasmProton Therapy
Start date
2015-12-01
Primary completion
2019-10-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.